Drug intelligence / Profile preview

Jieyu Chufan Jiaonang

Development stage
Unknown
Lead developer
Yiling Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Jieyu Chufan Jiaonang is an approved oral traditional Chinese medicine capsule developed and manufactured by Yiling for the treatment of **mild to moderate depression** in patients meeting a specific traditional Chinese medicine syndrome pattern associated with qi stagnation, phlegm obstruction, and internal depressive heat. It is a multi-herb fixed formulation derived from modifications of the classical formulas Banxia Houpu Tang and Zhizi Houpu Tang, and contains *Gardenia jasminoides* fruit, processed *Magnolia officinalis* bark, processed *Pinellia ternata*, *Forsythia suspensa*, *Poria cocos*, *Perilla* stem, *Citrus aurantium*, and licorice. Its claimed therapeutic action in TCM terms is to resolve depression, transform phlegm, clear heat, and relieve vexation; modern pharmacology described publicly is limited, but nonclinical studies cited by the manufacturer report antidepressant-like behavioral effects in animal models, and phase 2 and 3 Chinese trials used fluoxetine as an active comparator in mild to moderate depression. The product was approved in China in 2021 as an innovative TCM drug.

Other names
Depression-resolving and Restlessness-relieving Capsules解郁除烦胶囊

Beyond the preview

Go deeper on Jieyu Chufan Jiaonang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jieyu Chufan Jiaonang.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call